Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 121 Results

Title
Intervention Indication Therapeutic Area Year Actions
Zolbetuximab with nab-paclitaxel and gemcitabine for previously untreated metastatic CLDN18.2-positive pancreatic adenocarcinoma Gemcitabine (Gemzar; gemcitabine hydrochloride) , Nab-Paclitaxel (Abraxane; ABI 007; ABI-007) , Zolbetuximab (IMAB362) Pancreatic cancer Gastrointestinal Cancer 2024 View  |  Download
Zavegepant for treating acute migraine Zavegepant (BHV-3500) Migraine Neurology 2024 View  |  Download
Vutrisiran for treating transthyretin amyloidosis with cardiomyopathy Vutrisiran (ALN-TTRSC02) Transthyretin amyloid cardiomyopathy Cardiovascular System 2024 View  |  Download
Vosoritide for treating achondroplasia in children Vosoritide (BMN 111) Achondroplasia Musculoskeletal System 2024 View  |  Download
Vimseltinib for treating Tenosynovial Giant Cell Tumour Vimseltinib (DCC-3014) Tenosynovial giant cell tumour (TGCT) Oncology 2024 View  |  Download
Venetoclax with azacitidine for treating acute myeloid leukaemia following allogeneic stem cell transplantation Azacitidine (Vidaza; CC-486) , Venetoclax (Venclyxto; ABT-199; Venclexta; GDC-0199) Acute myeloid leukaemia (AML) Haematological Cancer and Lymphomas 2024 View  |  Download
Troriluzole for spinocerebellar ataxia Troriluzole Spinocerebellar ataxia Genetic Disorders , Neurology 2024 View  |  Download
Trastuzumab deruxtecan for treating previously untreated locally advanced or metastatic non-small cell lung cancer with HER2 mutations Trastuzumab deruxtecan (DS-8201a; Enhertu) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2024 View  |  Download
Trastuzumab deruxtecan for treating locally advanced, unresectable, or metastatic HER2+ solid tumours Trastuzumab deruxtecan (DS-8201a; Enhertu) Solid tumours Haematological Cancer and Lymphomas 2024 View  |  Download
Trastuzumab deruxtecan adjuvant treatment of high-risk HER2-positive, residual invasive breast cancer after neoadjuvant therapy Trastuzumab deruxtecan (DS-8201a; Enhertu) Breast cancer Breast Cancer 2024 View  |  Download
1 2 3 12 13
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications